A phase III randomised, double-blind trial of immunotherapy with a polyvalent melanoma vaccine (C-VAX) [Canvaxin; cancer vaccine] plus Bacille Calmette-Guerin (BCG) versus placebo plus BCG as a post surgical treatment for stage IV melanoma
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2009
At a glance
- Drugs Cancer vaccine (Primary) ; BCG
- Indications Malignant melanoma
- Focus Therapeutic Use
- 13 Aug 2009 Actual end date (Aug 2003) added as reported by ISRCTN: Current Controlled Trials record.
- 13 Aug 2009 Actual initiation date (1 Apr 1999), lead trial centres added as reported by ISRCTN: Current Controlled Trials record.
- 01 Mar 2006 New trial record.